Date | Time | Source | Headline | Symbol | Company |
02/23/2018 | 8:27AM | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/16/2018 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/16/2018 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/16/2018 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/16/2018 | 6:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/15/2018 | 4:49PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/15/2018 | 4:41PM | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/14/2018 | 6:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/14/2018 | 6:08PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 5:07PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 5:06PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 5:05PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 5:02PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 5:01PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 5:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 5:00PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 4:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 4:55PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 4:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 4:49PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 4:49PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 4:10PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 3:51PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 11:17AM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 11:13AM | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 10:59AM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 10:55AM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |
02/13/2018 | 10:53AM | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:SCMP | Sucampo Pharmaceuticals, Inc. (delisted) |